Annals of Behavioral Medicine

, Volume 49, Issue 3, pp 319–330 | Cite as

Mindfulness Meditation Alleviates Fibromyalgia Symptoms in Women: Results of a Randomized Clinical Trial

  • Elizabeth Cash
  • Paul Salmon
  • Inka Weissbecker
  • Whitney N. Rebholz
  • René Bayley-Veloso
  • Lauren A. Zimmaro
  • Andrea Floyd
  • Eric Dedert
  • Sandra E. Sephton
Original Article



Several recent reviews have evaluated evidence on the efficacy of Mindfulness-Based Stress Reduction (MBSR) among fibromyalgia sufferers, and concluded that more research should test effects on both psychological and physiological functioning.


We conducted a randomized prospective trial of MBSR among female fibromyalgia patients.


Effects on perceived stress, pain, sleep quality, fatigue, symptom severity, and salivary cortisol were tested in treatment (n = 51) versus wait-list control participants (n = 40) using data at baseline, post-program, and 2-month follow-up.


Analyses revealed that MBSR significantly reduced perceived stress, sleep disturbance, and symptom severity, with gains maintained at follow-up. Greater home practice at follow-up was associated with reduced symptom severity. MBSR did not significantly alter pain, physical functioning, or cortisol profiles.


MBSR ameliorated some of the major symptoms of fibromyalgia and reduced subjective illness burden. Further exploration of MBSR effects on physiological stress responses is warranted. These results support use of MBSR as a complementary treatment for women with fibromyalgia (ISRCTN: 34628811).


Fibromyalgia Mindfulness meditation Perceived stress Sleep Cortisol 



This was an investigator-initiated study funded by faculty startup monies awarded to S.E.S by the Department of Psychiatry and Behavioral Sciences at the University of Louisville School of Medicine. A.F. was supported by a grant from the National Cancer Institute. L.A.Z. was supported by a doctoral fellowship from the University of Louisville School of Interdisciplinary and Graduate Studies. S.E.S. was supported by grants from the National Institute on Aging and the National Institute of Mental Health. E.D. was supported by a Career Development Award-2 from the Clinical Science Research and Development Service of the VA Office of Research and Development. The funders played no role in the design, conduct or analysis of the study, nor in the interpretation and reporting of the study findings. The researchers were independent from the funders. All authors, external and internal, had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.

Authors’ Statement of Conflict of Interest and Adherence to Ethical Standards

Author Elizabeth Cash, Author Paul Salmon, Author Inka Weissbecker, Author Whitney N. Rebholz, Author Rene Bayley-Veloso, Author Lauren Zimmaro, Author Andrea Floyd, Author Eric Dedert, and Author Sandra E. Sephton declare that they have no conflict of interest. All procedures, including the informed consent process, were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.


  1. 1.
    Wolfe F, Clauw DJ, Fitzcharles M-A, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010; 62(5): 600-610. doi: 10.1002/acr.20140.CrossRefGoogle Scholar
  2. 2.
    Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007; 8(1): 27. doi: 10.1186/1471-2474-8-27.CrossRefPubMedCentralPubMedGoogle Scholar
  3. 3.
    Rutledge DN, Jones K, Jones CJ. Predicting high physical function in people with fibromyalgia. J Nurs Scholarsh. 2007; 39(4): 319-324. doi: 10.1111/j.1547-5069.2007.00187.x.CrossRefPubMedGoogle Scholar
  4. 4.
    Shillam CR, Dupree Jones K, Miller L. Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults. Nurs. Res. 2011;1: doi:10.1097/NNR.0b013e31822bbdfa.Google Scholar
  5. 5.
    Crofford LJ. Violence, stress, and somatic syndromes. Trauma Violence Abuse. 2007; 8(3): 299-313. doi: 10.1177/1524838007303196.CrossRefPubMedGoogle Scholar
  6. 6.
    Van Houdenhove BV, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep. 2005; 7(5): 365-370. doi: 10.1007/s11926-005-0021-z.CrossRefPubMedGoogle Scholar
  7. 7.
    Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol. 2005; 75: 6-21.Google Scholar
  8. 8.
    McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl. 1989; 19: 154-157.Google Scholar
  9. 9.
    Weissbecker I, Salmon P, Studts JL, Floyd AR, Dedert EA, Sephton SE. Mindfulness-based stress reduction and sense of coherence among women with fibromyalgia. J Clin Psychol Med Settings. 2002; 9(4): 297-307. doi: 10.1023/A:1020786917988.CrossRefGoogle Scholar
  10. 10.
    McLean SA, Williams DA, Harris RE, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum. 2005; 52(11): 3660-3669. doi: 10.1002/art.21372.CrossRefPubMedGoogle Scholar
  11. 11.
    Korszun A. Sleep and circadian rhythm disorders in fibromyalgia. Curr Rheumatol Rep. 2000; 2(2): 124-130. doi: 10.1007/s11926-000-0052-4.CrossRefPubMedGoogle Scholar
  12. 12.
    Hellhammer DH, Wüst S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009; 34(2): 163-171. doi: 10.1016/j.psyneuen.2008.10.026.CrossRefPubMedGoogle Scholar
  13. 13.
    Wilhelm I, Born J, Kudielka BM, Schlotz W, Wüst S. Is the cortisol awakening rise a response to awakening? Psychoneuroendocrinology. 2007; 32(4): 358-366. doi: 10.1016/j.psyneuen.2007.01.008.CrossRefPubMedGoogle Scholar
  14. 14.
    Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med. 1999; 61(2): 197-204.CrossRefPubMedGoogle Scholar
  15. 15.
    Kunz-Ebrecht SR, Kirschbaum C, Marmot M, Steptoe A. Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort. Psychoneuroendocrinology. 2004; 29(4): 516-528. doi: 10.1016/S0306-4530(03)00072-6.CrossRefPubMedGoogle Scholar
  16. 16.
    Hellhammer J, Fries E, Schweisthal OW, Schlotz W, Stone AA, Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology. 2007; 32(1): 80-86. doi: 10.1016/j.psyneuen.2006.10.005.CrossRefPubMedGoogle Scholar
  17. 17.
    Riva R, Mork PJ, Westgaard RH, Rø M, Lundberg U. Fibromyalgia syndrome is associated with hypocortisolism. Int J Behav Med. 2010; 17(3): 223-233. doi: 10.1007/s12529-010-9097-6.CrossRefPubMedGoogle Scholar
  18. 18.
    Riva R, Mork PJ, Westgaard RH, Lundberg U. Comparison of the cortisol awakening response in women with shoulder and neck pain and women with fibromyalgia. Psychoneuroendocrinology. 2012; 37(2): 299-306. doi: 10.1016/j.psyneuen.2011.06.014.CrossRefPubMedGoogle Scholar
  19. 19.
    Curtis K, Osadchuk A, Katz J. An eight-week yoga intervention is associated with improvements in pain, psychological functioning and mindfulness, and changes in cortisol levels in women with fibromyalgia. J Pain Res. 2011; 4: 189-201. doi: 10.2147/JPR.S22761.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Carlson LE, Speca M, Faris P, Patel KD. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun. 2007; 21(8): 1038-1049. doi: 10.1016/j.bbi.2007.04.002.CrossRefPubMedGoogle Scholar
  21. 21.
    Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005; 12(4): 278-285. doi: 10.1207/s15327558ijbm1204_9.CrossRefPubMedGoogle Scholar
  22. 22.
    Crofford LJ, Appleton BE. The treatment of fibromyalgia: a review of clinical trials. Curr Rheumatol Rep. 2000; 2(2): 101-103. doi: 10.1007/s11926-000-0048-0.CrossRefPubMedGoogle Scholar
  23. 23.
    Crofford LJ. Pain management in fibromyalgia. Curr Opin Rheumatol. 2008; 20(3): 246-250. doi: 10.1097/BOR.0b013e3282fb0268.CrossRefPubMedGoogle Scholar
  24. 24.
    Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: a meta-analysis. PAIN. 2010; 151(2): 280-295. doi: 10.1016/j.pain.2010.06.011.CrossRefPubMedGoogle Scholar
  25. 25.
    Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004; 292(19): 2388-2395. doi: 10.1001/jama.292.19.2388.CrossRefPubMedGoogle Scholar
  26. 26.
    Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract. 2003; 10(2): 144-156.CrossRefGoogle Scholar
  27. 27.
    Keng S-L, Smoski MJ, Robins CJ. Effects of mindfulness on psychological health: a review of empirical studies. Clin Psychol Rev. 2011; 31(6): 1041-1056. doi: 10.1016/j.cpr.2011.04.006.CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Shapiro SL. The integration of mindfulness and psychology. J Clin Psychol. 2009; 65(6): 555-560. doi: 10.1002/jclp.20602.CrossRefPubMedGoogle Scholar
  29. 29.
    Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res. 2010; 68(6): 539-544. doi: 10.1016/j.jpsychores.2009.10.005.CrossRefPubMedGoogle Scholar
  30. 30.
    Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010; 16(1): 13-19. doi: 10.1016/j.ctcp.2009.06.004.CrossRefPubMedGoogle Scholar
  31. 31.
    Sephton SE, Salmon P, Weissbecker I, et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Care Res. 2007; 57(1): 77-85. doi: 10.1002/art.22478.CrossRefGoogle Scholar
  32. 32.
    Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007; 76(4): 226-233.CrossRefPubMedGoogle Scholar
  33. 33.
    Schmidt S, Grossman P, Schwarzer B, Jena S, Naumann J, Walach H. Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial. PAIN. 2011; 152(2): 361-369. doi: 10.1016/j.pain.2010.10.043.CrossRefPubMedGoogle Scholar
  34. 34.
    Lush E, Salmon P, Floyd A, Studts JL, Weissbecker I, Sephton SE. Mindfulness meditation for symptom reduction in fibromyalgia: psychophysiological correlates. J Clin Psychol Med Settings. 2009; 16(2): 200-207. doi: 10.1007/s10880-009-9153-z.CrossRefPubMedGoogle Scholar
  35. 35.
    Kaplan KH, Goldenberg DL, Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry. 1993; 15(5): 284-289. doi: 10.1016/0163-8343(93)90020-O.CrossRefPubMedGoogle Scholar
  36. 36.
    Goldenberg DL, Kaplan KH, Nadeau MG, Brodeur C, Smith S, Schmid CH. A controlled study of a stress-reduction, cognitive-behavioral treatment program in fibromyalgia. J Musculoskelet Pain. 1994; 2(2): 53-66. doi: 10.1300/J094v02n02_05.CrossRefGoogle Scholar
  37. 37.
    Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol. 2006; 62(3): 373-386. doi: 10.1002/jclp.20237.CrossRefPubMedGoogle Scholar
  38. 38.
    Salmon P, Sephton S, Weissbecker I, Hoover K, Ulmer C, Studts JL. Mindfulness meditation in clinical practice. Cogn Behav Pract. 2004; 11(4): 434-446. doi: 10.1016/S1077-7229(04)80060-9.CrossRefGoogle Scholar
  39. 39.
    Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988; 8(1): 77-100. doi: 10.1016/0272-7358(88)90050-5.CrossRefGoogle Scholar
  40. 40.
    Bernstein DP, Fink L. Childhood Trauma Questionnaire: A Retrospective Self-Report: Manual. Harcourt Brace & Company; 1998.Google Scholar
  41. 41.
    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 24(4): 385. doi: 10.2307/2136404.CrossRefPubMedGoogle Scholar
  42. 42.
    Callahan LF, Brooks RH, Summey JA, Pincus T. Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and a visual analog pain scale. Arthritis Rheum. 1987; 30(6): 630-636. doi: 10.1002/art.1780300605.CrossRefPubMedGoogle Scholar
  43. 43.
    Douglass A, Bornstein R, Nino-Murcia G, et al. Sleep disorders questionnaire. Sleep. 1994; 17(2): 160-167.PubMedGoogle Scholar
  44. 44.
    Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory. Qual Life Res. 1998; 7(4): 301-310. doi: 10.1023/A:1024929829627.CrossRefPubMedGoogle Scholar
  45. 45.
    Burckhardt CS, Clark SR, Bennett RM, et al. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991; 18(5): 728-33.PubMedGoogle Scholar
  46. 46.
    Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005; 23(5): S154.PubMedGoogle Scholar
  47. 47.
    Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994; 19(4): 313-333. doi: 10.1016/0306-4530(94)90013-2.CrossRefPubMedGoogle Scholar
  48. 48.
    Pledger GW. Basic statistics: importance of compliance. J Clin Res Pharmacoepidemiol. 1992; 6(2): 77-81.Google Scholar
  49. 49.
    Friedman LM, Furberg C, DeMets DL. Fundamentals of Clinical Trials. New York, NY: Springer; 2010. Available at: 10.1007/978-1-4419-1586-3.pdf. Accessed September 5, 2014.Google Scholar
  50. 50.
    Lachin JM. Statistical considerations in the intent-to-treat principle. Control Clin Trials. 2000; 21(3): 167-189. doi: 10.1016/S0197-2456(00)00046-5.CrossRefPubMedGoogle Scholar
  51. 51.
    Lambert MJ, ed. Bergin and Garfield’s Handbook of Psychotherapy and Behavior Change. 5th ed. New York, NY: Wiley; 2004.Google Scholar
  52. 52.
    Hughes JW, Fresco DM, Myerscough R, van Dulmen HM, Carlson LE, Josephson R. Randomized controlled trial of mindfulness-based stress reduction for prehypertension. Psychosom Med. 2013; 75(8): 721-728. doi: 10.1097/PSY.0b013e3182a3e4e5.CrossRefPubMedGoogle Scholar
  53. 53.
    Salmon P, Sephton S, Dreeben, S. Mindfulness-based stress reduction. In: Herbert JD, Forman E, eds. Acceptance and mindfulness in cognitive behavioral therapy. NJ: Wiley; 2011.Google Scholar
  54. 54.
    Kraemer H, Wilson G, Fairburn CG, Agras W. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002; 59(10): 877-883. doi: 10.1001/archpsyc.59.10.877.CrossRefPubMedGoogle Scholar
  55. 55.
    Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Für Rheumatol. 1998; 57(2): S94-S96. doi: 10.1007/s003930050245.CrossRefGoogle Scholar
  56. 56.
    Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004; 66(6): 837-844.CrossRefPubMedGoogle Scholar
  57. 57.
    Teasdale JD, Segal ZV, Mark J, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000; 68(4): 615-623. doi: 10.1037/0022-006X.68.4.615.CrossRefPubMedGoogle Scholar
  58. 58.
    Astin JA, Berman BM, Bausell B, Lee W-L, Hochberg M, Forys KL. The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial. J Rheumatol. 2003; 30(10): 2257-2262.PubMedGoogle Scholar
  59. 59.
    Rosenzweig S, Greeson JM, Reibel DK, Green JS, Jasser SA, Beasley D. Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res. 2010; 68(1): 29-36. doi: 10.1016/j.jpsychores.2009.03.010.CrossRefPubMedGoogle Scholar
  60. 60.
    Singh BB, Berman BM, Hadhazy VA, Creamer P. A pilot study of cognitive behavioral therapy in fibromyalgia. Altern Ther Health Med. 1998; 4(2): 67-70.PubMedGoogle Scholar
  61. 61.
    Chiesa A, Serretti A. Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. J Altern Complement Med. 2009; 15(5): 593-600. doi: 10.1089/acm.2008.0495.CrossRefPubMedGoogle Scholar
  62. 62.
    Musial F, Büssing A, Heusser P, Choi K-E, Ostermann T. Mindfulness-based stress reduction for integrative cancer care—a summary of evidence. Forsch Komplementärmedizin Res Complement Med. 2011; 18(4): 192-202. doi: 10.1159/000330714.CrossRefGoogle Scholar
  63. 63.
    Hölzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci. 2011; 6(6): 537-559. doi: 10.1177/1745691611419671.CrossRefGoogle Scholar
  64. 64.
    Ditto B, Eclache M, Goldman N. Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Ann Behav Med. 2006; 32(3): 227-234. doi: 10.1207/s15324796abm3203_9.CrossRefPubMedGoogle Scholar
  65. 65.
    Pace TWW, Negi LT, Adame DD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. 2009; 34(1): 87-98. doi: 10.1016/j.psyneuen.2008.08.011.CrossRefPubMedCentralPubMedGoogle Scholar
  66. 66.
    Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003; 65(4): 571-581. doi: 10.1097/01.PSY.0000074003.35911.41.CrossRefPubMedGoogle Scholar
  67. 67.
    Davidson RJ, Kabat-Zinn J, Schumacher J, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. 2003; 65(4): 564-570.CrossRefPubMedGoogle Scholar
  68. 68.
    Baer RA. Self-focused attention and mechanisms of change in mindfulness-based treatment. Cogn Behav Ther. 2009; 38(sup1): 15-20. doi: 10.1080/16506070902980703.CrossRefPubMedGoogle Scholar
  69. 69.
    Shapiro SL, Astin JA, Bishop SR, Cordova M. Mindfulness-based stress reduction for health care professionals: results from a randomized trial. Int J Stress Manag. 2005; 12(2): 164-176. doi: 10.1037/1072-5245.12.2.164.CrossRefGoogle Scholar
  70. 70.
    Jain S, Shapiro SL, Swanick S, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med. 2007; 33(1): 11-21. doi: 10.1207/s15324796abm3301_2.CrossRefPubMedGoogle Scholar
  71. 71.
    Teasdale JD. Emotional processing, three modes of mind and the prevention of relapse in depression. Behav Res Ther. 1999; 37(Supplement 1): S53-S77. doi: 10.1016/S0005-7967(99)00050-9.CrossRefPubMedGoogle Scholar
  72. 72.
    Garland E, Gaylord S, Park J. The role of mindfulness in positive reappraisal. EXPLORE J Sci Heal. 2009; 5(1): 37-44. doi: 10.1016/j.explore.2008.10.001.CrossRefGoogle Scholar
  73. 73.
    Alan B, Shapiro SL. Mental balance and well-being: building bridges between Buddhism and western psychology. Am Psychol. 2006; 61(7): 690-701. doi: 10.1037/0003-066X.61.7.690.CrossRefGoogle Scholar
  74. 74.
    Hofmann SG, Asmundson GJG. Acceptance and mindfulness-based therapy: new wave or old hat? Clin Psychol Rev. 2008; 28(1): 1-16. doi: 10.1016/j.cpr.2007.09.003.CrossRefPubMedGoogle Scholar
  75. 75.
    Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York, NY: Springer Publishing Company; 1984.Google Scholar
  76. 76.
    Narkiewicz K, van de Borne P, Montano N, Hering D, Kara T, Somers VK. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertens. 2006; 47(1): 51-55. doi: 10.1161/01.HYP.0000197613.47649.02.CrossRefGoogle Scholar
  77. 77.
    Lehrer PM, Woolfolk RL, Sime WE. Principles and Practice of Stress Management, Third Edition. New York, NY: Guilford Press; 2007.Google Scholar
  78. 78.
    Khalsa SB. Yoga as a therapeutic intervention: a bibliometric analysis of published research studies. Indian J Physiol Pharmacol. 2004; 48(3): 269-285.PubMedGoogle Scholar
  79. 79.
    Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001; 1(1): 2.CrossRefPubMedCentralPubMedGoogle Scholar
  80. 80.
    Yunus MB, Arslan S, Aldag JC. Relationship between fibromyalgia features and smoking. Scand J Rheumatol. 2002; 31(5): 301-305. doi: 10.1080/030097402760375214.CrossRefPubMedGoogle Scholar
  81. 81.
    Shapiro SL, Oman D, Thoresen CE, Plante TG, Flinders T. Cultivating mindfulness: effects on well-being. J Clin Psychol. 2008; 64(7): 840-862. doi: 10.1002/jclp.20491.CrossRefPubMedGoogle Scholar
  82. 82.
    Baer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report the Kentucky inventory of mindfulness skills. Assess. 2004; 11(3): 191-206. doi: 10.1177/1073191104268029.CrossRefGoogle Scholar
  83. 83.
    Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003; 84(4): 822-848. doi: 10.1037/0022-3514.84.4.822.CrossRefPubMedGoogle Scholar
  84. 84.
    Chadwick P, Hember M, Symes J, Peters E, Kuipers E, Dagnan D. Responding mindfully to unpleasant thoughts and images: reliability and validity of the Southampton mindfulness questionnaire (SMQ). Br J Clin Psychol. 2008; 47(4): 451-455. doi: 10.1348/014466508X314891.CrossRefPubMedGoogle Scholar
  85. 85.
    Carmody J, Baer RA, LB Lykins E, Olendzki N. An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program. J Clin Psychol. 2009; 65(6): 613-626. doi: 10.1002/jclp.20579.CrossRefPubMedGoogle Scholar
  86. 86.
    Kilpatrick LA, et al. Impact of mindfulness-based stress reduction training on intrinsic brain connectivity. Neuroimage 2011;56(1): 290-298.Google Scholar
  87. 87.
    Salmon P, Lush E, Jablonski M, Sephton SE (2008) Yoga and Mindfulness: Clinical Aspects of an Ancient Mind/Body Practice. Cognitive and Behavioral Practice. doi: 10.1016/j.cbpra.2008.07.002.
  88. 88.
    Sampalli T, Berlasso E, Fox R, Petter M. A controlled study of the effect of a mindfulness-based stress reduction technique in women with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia. J Multidiscip Healthc. 2009; 2: 53-59.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2014

Authors and Affiliations

  • Elizabeth Cash
    • 1
    • 2
    • 3
  • Paul Salmon
    • 3
  • Inka Weissbecker
    • 4
  • Whitney N. Rebholz
    • 3
  • René Bayley-Veloso
    • 3
  • Lauren A. Zimmaro
    • 3
  • Andrea Floyd
    • 5
  • Eric Dedert
    • 6
    • 7
  • Sandra E. Sephton
    • 2
    • 3
  1. 1.Department of Surgery, Division of OtolaryngologyUniversity of Louisville School of MedicineLouisvilleUSA
  2. 2.James Graham Brown Cancer CenterLouisvilleUSA
  3. 3.Department of Psychological and Brain SciencesUniversity of LouisvilleLouisvilleUSA
  4. 4.International Medical Corps UKLondonUK
  5. 5.Robley Rex Veterans Affairs Medical CenterLouisvilleUSA
  6. 6.Durham Veterans Affairs Medical CenterDurhamUSA
  7. 7.Department of Psychiatry & Behavioral SciencesDuke University Medical CenterDurhamUSA

Personalised recommendations